These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 38672195)

  • 1. Non-Mammalian Models for Understanding Neurological Defects in RASopathies.
    Rodríguez-Martín M; Báez-Flores J; Ribes V; Isidoro-García M; Lacal J; Prieto-Matos P
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Aspects of RASopathies.
    Kim YE; Baek ST
    Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618
    [No Abstract]   [Full Text] [Related]  

  • 3. RASopathies for Radiologists.
    Handa A; Tsujioka Y; Nishimura G; Nozaki T; Kono T; Jinzaki M; Harms T; Connolly SA; Sato TS; Sato Y
    Radiographics; 2024 May; 44(5):e230153. PubMed ID: 38602868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASopathies: unraveling mechanisms with animal models.
    Jindal GA; Goyal Y; Burdine RD; Rauen KA; Shvartsman SY
    Dis Model Mech; 2015 Aug; 8(8):769-82. PubMed ID: 26203125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic perspectives in Noonan syndrome and RASopathies.
    Saint-Laurent C; Mazeyrie L; Yart A; Edouard T
    Eur J Pediatr; 2024 Mar; 183(3):1011-1019. PubMed ID: 37863846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASopathies and cardiac manifestations.
    Hilal N; Chen Z; Chen MH; Choudhury S
    Front Cardiovasc Med; 2023; 10():1176828. PubMed ID: 37529712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Genetics of Noonan Syndrome and RASopathies.
    Liao J; Mehta L
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes.
    de Carvalho JB; de Morais GL; Vieira TCDS; Rabelo NC; Llerena JC; Gonzalez SMC; de Vasconcelos ATR
    Front Genet; 2019; 10():1144. PubMed ID: 31798637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific roles of RAS-MAPK signaling in learning and memory: Implications in neurodevelopmental disorders.
    Ryu HH; Lee YS
    Neurobiol Learn Mem; 2016 Nov; 135():13-21. PubMed ID: 27296701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.
    Patterson VL; Burdine RD
    Birth Defects Res; 2020 Jun; 112(10):749-765. PubMed ID: 32506834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RASopathies: from pathogenetics to therapeutics.
    Hebron KE; Hernandez ER; Yohe ME
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling RASopathies with Genetically Modified Mouse Models.
    Hernández-Porras I; Guerra C
    Methods Mol Biol; 2017; 1487():379-408. PubMed ID: 27924582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASopathies are associated with a distinct personality profile.
    Bizaoui V; Gage J; Brar R; Rauen KA; Weiss LA
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):434-446. PubMed ID: 29659143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RASopathies.
    Rauen KA
    Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo severity ranking of Ras pathway mutations associated with developmental disorders.
    Jindal GA; Goyal Y; Yamaya K; Futran AS; Kountouridis I; Balgobin CA; Schüpbach T; Burdine RD; Shvartsman SY
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):510-515. PubMed ID: 28049852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype-phenotype relationship in RASopathies.
    Yoon JG; Yu JW; Shim KW; Kim YO; Lee MG
    Clin Genet; 2024 Aug; 106(2):199-203. PubMed ID: 38679877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetics of the RASopathies.
    Tidyman WE; Rauen KA
    Hum Mol Genet; 2016 Oct; 25(R2):R123-R132. PubMed ID: 27412009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.